• Citer

A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer.

par Skovsgaard, T;Davidson, N G;Piccart-Gebhart, Martine ;Richel, D J;Bonneterre, J;Cirkel, D T;Barton, C M;Eniluracil/Fluorouracil Breast Cancer Study Group,
Référence Annals of oncology, 12, 9, page (1255-1257)
Publication Publié, 2001-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer.
Auteur:	Skovsgaard, T; Davidson, N G; Piccart-Gebhart, Martine; Richel, D J; Bonneterre, J; Cirkel, D T; Barton, C M; Eniluracil/Fluorouracil Breast Cancer Study Group,
Informations sur la publication:	Annals of oncology, 12, 9, page (1255-1257)
Statut de publication:	Publié, 2001-09
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Administration, Oral
	Adult
	Aged
	Antibiotics, Antineoplastic -- pharmacology
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Bridged Compounds -- pharmacology
	Drug Resistance, Neoplasm
	Female
	Fluorouracil -- administration & dosage
	Humans
	Middle Aged
	Taxoids
	Treatment Outcome
	Uracil -- administration & dosage
	Uracil -- analogs & derivatives
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1023/A:1012249630074
	info:scp/0034777468
	info:pmid/11697836